Search

everythinglearnresearchcommunity

for

Search:↓

Severe baldness on the top of the head is linked to a higher chance of heart disease, especially in men under 60.

Antioxidants may help fight oxidative stress linked to autoimmune skin diseases.

AA patients with comorbid conditions face more severe hair loss and need specific treatments.

Aromatase inhibitor therapy for breast cancer increases the risk of hair loss and thinning.

Different types of fibroblasts play specific roles in wound healing and cancer, which could help improve treatments.

Researchers found a specific immune receptor in patients that causes severe skin reactions to a drug.

Elastic Net DNA methylation clocks are inaccurate for predicting age and health status; a "noise barometer" may better indicate aging and disease.

Certain gut bacteria may increase or decrease the risk of male pattern baldness.

Kawasaki's disease can occur in adults and should be considered with specific symptoms and high ferritin levels.

The 2023 guideline advises a detailed approach for PCOS, focusing on early detection, lifestyle and medical treatments, and managing health risks.

The 2023 guideline for PCOS suggests using updated diagnostic criteria, assessing related health risks, and recommends lifestyle changes and specific treatments for symptoms and fertility issues.

Minoxidil can cause dangerous fluid buildup around the heart.

Carboplatin-paclitaxel is preferred for advanced lung cancer due to its balance of affordability and patient well-being.

Monitor for early signs of azathioprine toxicity and check blood counts regularly.

The FDA warned about safety issues with remdesivir and tofacitinib, finasteride is linked to suicidality, potent topical corticosteroids increase osteoporosis risk, henna can cause hemolysis in G6PD deficiency, chemotherapeutic agents can cause adverse reactions, drug interactions are common in cancer patients, ketamine can reduce at-risk drinking, high dose of anticholinergics increases dementia risk in Parkinson's patients, and prenatal exposure to second-generation antipsychotics increases pregnancy complications.

Certain skin conditions may indicate or increase the risk of Parkinson's disease.

Certain fats in the blood are linked to an increased risk of male pattern baldness.

Minoxidil doesn't increase pericardial disorder risk, but may cause fluid accumulation.

Psoriasis involves immune and genetic factors, and understanding these can improve treatments.

People with certain skin conditions, especially androgenic alopecia, are more likely to have metabolic syndrome.

Shen-Min, a hair growth supplement, likely caused acute hepatitis in a woman, improving after she stopped taking it.

Long COVID causes a wide range of long-lasting symptoms that change over time and are hard to diagnose and treat.

Combined oral minoxidil and finasteride significantly improve hair density in men with male pattern baldness.

Hair microscopy is useful for diagnosing certain hair loss conditions but has limitations and must be interpreted carefully.

Genetic and environmental factors, like smoking and exercise, affect male hair loss.

Wild geladas in crop areas show less grooming and aggression.

Ritlecitinib is safe and well-tolerated for treating alopecia areata in patients aged 12 and older.

Synthetic antioxidants are effective, cheap, and stable, with some like zinc and cholecalciferol reducing child and cancer deaths, but the safety of additives like BHA, BHT, TBHQ, and PEG needs more research.

The updated GRADE guidance advises considering context when interpreting variability in research results and introduces tools for assessing subgroup effects.

The review suggests younger men taking 1 mg finasteride report more side effects, including sexual, skin, metabolic, and psychological issues.